1-(1-methyl-pyrrolidin-2-yl)-propan-1-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: 1-(1-methyl-pyrrolidin-2-yl)-propan-1-one
• 英文别名: 1-(1-Methyl-pyrrolidin-2-yl)-propan-1-on；1-(1-Methylpyrrolidin-2-yl)propan-1-one
• 化学式: C₈H₁₅NO
• 分子量: 141.213
• InChiKey: BCSDRBQMHIMWHO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-pyrrolidin-2-yl-propan-1-ol 、 盐酸 、 聚合甲醛 生成 1-(1-methyl-pyrrolidin-2-yl)-propan-1-one
  参考文献：
  名称：

  Hess, Chemische Berichte, 1913, vol. 46, p. 3123

  摘要：

  DOI：

文献信息

• BETULONIC AND BETULINIC ACID DERIVATIVES
  申请人：Leunis Jean-Claude

  公开号：US20090068257A1

  公开（公告）日：2009-03-12

  The present invention relates to betulonic and betulinic acid derivatives and, in particular, to C-28 and C-3 derivatives. The present invention relates to betulonic acid esters, dihydro-betulonic acid esters, PAG-modified betulinic acid derivatives, and PAG-modified dihydro-betulinic acid derivatives. Betulinic acid and derivatives thereof may be bound to a poly(alkylene glycol) (PAG) such as poly(ethylene glycol). Binding may be via a linker, such as a diamine, an amino acid, a peptide, an ester or a carbonate. The compounds of the present invention may be used for the treatment of cancer or a viral infection. The present invention also provides pharmaceutical compositions comprising the compounds of the present invention. The present invention further provides processes for the preparation of the compounds of the present invention, for example, from betulin.

  本发明涉及白桦酸和白桦皮酸衍生物，特别是C-28和C-3衍生物。本发明涉及白桦酸酯、二氢白桦酸酯、PAG修饰的白桦皮酸衍生物和PAG修饰的二氢白桦皮酸衍生物。白桦皮酸及其衍生物可以与聚（烯基氧化物）（PAG）如聚（乙二醇）结合。结合可以通过连接剂，例如二胺、氨基酸、肽、酯或碳酸酯实现。本发明的化合物可用于癌症或病毒感染的治疗。本发明还提供了包含本发明化合物的制药组合物。本发明还提供了制备本发明化合物的方法，例如从白桦中制备。
• NITROGEN-CONTAINING HETEROCYCLIC COMPOUND
  申请人：KYOWA HAKKO KIRIN CO., LTD.

  公开号：US20150299214A1

  公开（公告）日：2015-10-22

  The present invention provides a heterocyclic compound represented by the following formula (I), wherein X A represents CH and the like, R 1 represents cycloalkyl optionally having substituent(s) and the like, L represents a bond and the like, Y A represents —NH— and the like, R 2 represents a hydrogen atom and the like, R 3A represents the following formula (R 3A -1) (wherein, R 3 represents hydroxy and the like) and the like, and R 4A represents the following formula (R 4A -1) (wherein, R 4 and R 5 are the same or different and each represents a hydrogen atom and the like) and the like, or a pharmaceutically acceptable salt thereof, which is useful as a prophylactic and/or therapeutic agent for skin diseases and the like, and the like.

  本发明提供一种杂环化合物，其化学式表示为（I），其中XA代表CH等，R1代表环烷基，可选地具有取代基等，L代表键等，YA代表—NH—等，R2代表氢原子等，R3A代表下式（R3A-1）（其中，R3代表羟基等）等，R4A代表下式（R4A-1）（其中，R4和R5相同或不同，且每个代表氢原子等）等，或其药学上可接受的盐，其作为预防和/或治疗皮肤疾病等的药物具有用途。
• DE287802
  申请人：——

  公开号：——

  公开（公告）日：——
• Hess, Chemische Berichte, 1913, vol. 46, p. 4106
  作者：Hess

  DOI：——

  日期：——
• ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
  申请人：Geller Bruce L.

  公开号：US20150361425A1

  公开（公告）日：2015-12-17

  Provided are antisense morpholino oligomers targeted against bacterial virulence factors such as genes that contribute to antibiotic resistance or biofilm formation, or genes associated with fatty acid biosynthesis, and related compositions and methods of using the oligomers and compositions, for instance, in the treatment of an infected mammalian subject.